DoW Toxic Exposures Translational Research Award

The Department of the Army, through the Defense Health Agency, is soliciting applications for the fiscal year 2026 Toxic Exposures Research Program Translational Research Award. This initiative aims to accelerate the transition of military-related toxic exposure research into clinical applications, such as healthcare products, interventions, technologies, and clinical practice guidelines. The program focuses on predicting, preventing, diagnosing, and treating effects from neurotoxin exposure, Gulf War Illness, airborne hazards, burn pits, and other service-related exposures. To foster interdisciplinary collaboration, the award includes a Partnering Principal Investigator Option, allowing an initiating PI to collaborate with a partnering PI on separate but linked awards. The funding opportunity provides approximately 6 million dollars to support four awards, with a cost cap of 1.5 million dollars per award over a three-year period of performance. The application process is a two-step requirement, starting with a pre-application due August 19, 2026, followed by a full application due November 19, 2026. Submissions must be made via eBRAP for pre-applications and either eBRAP or Grants.gov for full applications, depending on whether the organization is intramural or extramural. Selection is based on a two-tier review process consisting of a peer review for technical merit and a programmatic review for military relevance. Certain research areas are strictly excluded, including classified data, fourth-generation chemical warfare agents, biological select agents, Havana Syndrome, and directed energy weapons.